Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862199 | 0.99 | ALOX5 (0.33) | ALOX5MAPTPOLBTSHRLMNA | |
| SCHEMBL19862117 | 0.96 | ALOX5 (0.33) | ALOX5MAPTPOLBTSHRLMNA | |
| SCHEMBL19862107 | 0.95 | ALOX5 (0.33) | ALOX5MAPTKMT2AALDH1A1HPGD | |
| SCHEMBL19862127 | 0.94 | ALOX5 (0.32) | ALOX5MAPTPOLBTSHRLMNA | |
| SCHEMBL19862105 | 0.92 | ALDH1A1 (0.35) | MAPTTSHRKMT2AALDH1A1HPGD | |
| SCHEMBL19862119 | 0.91 | LMNA (0.30) | MAPTPOLBTSHRLMNAHTT | |
| SCHEMBL19864870 | 0.91 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL19862108 | 0.90 | LMNA (0.31) | ALOX5MAPTPOLBTSHRLMNA | |
| SCHEMBL18156835 | 0.89 | ALOX5 (0.36) | ALOX5MAPTPOLBTSHRLMNA | |
| SCHEMBL14681706 | 0.89 | ALOX5 (0.36) | ALOX5MAPTPOLBTSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454039-B2 | Compound and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2019-10-22 | — | — | US | disclosed |
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | ORC3, AOX1, RCOR3 | ALOX5 4218/4885MAPT 4375/4885POLB 1982/4885 |
| US-10454039-B2 | Compound and organic electronic device using the same | ORC3, AOX1, RCOR3 | ALOX5 4218/4885MAPT 4375/4885POLB 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.